Skip to main content
Caplight Logo









Bioscibex

Bioscibex

Private
MontheyHealthcare & Life Scienceshttps://www.bioscibex.com/

Last Round

Grant

Feb 3, 2026

Total Funding Raised

$1.23M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Bioscibex is a biotechnology company developing single-use bioreactors for bioproduction.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Smart Manufacturing

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

bioreactorsingle-use bioreactorcell culturebioprocessing equipmentbiologics manufacturingCDMOcontract development and manufacturing organizationmonoclonal antibody productionrazor-and-blades modelbiotech hardwarebioprocessing consumableslab automationclosed-system manufacturingbiotech manufacturing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bioscibex Comparables

Compare Bioscibex with similar companies based on industry and business-model similarity.

Bioscibex comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stobbe Group
77%
PBS Biotech
77%
Merck
76%

Bioscibex Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 3, 2026
VC RoundFeb 3, 2026
GrantSep 29, 2025
DebtMar 17, 2025
DebtMar 17, 2025

Key People

Founding team and executive leadership

François Carruzzo

Co-founder & CTO

Founding Team

Chloé Albietz

CEO & Co-founder

Founding Team

Bioscibex Investors

Notable investors and investment history

Bioscibex investors
InvestorRounds
Foundation for Technological InnovationDebt
KickfundGrant, VC Round
InnosuisseGrant
Venture KickGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 31, 2026

    Open roles increased to 4, representing 67% of headcount.

  • Aug 10, 2026

    Open roles increased to 3, 50% of headcount.

Bioscibex Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bioscibex Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bioscibex's valuation, stock price, and market status.

Firmographic Details

HeadquartersMonthey
Employee Range6
Year Founded2024
Last FundingFeb 3, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?